- Start date
- 03 Oct 2024
- End date
- 04 Oct 2024
- Location
- Lugano, Switzerland
Learning objectives
- Provide a state-of-the art overview on evidence-based perioperative strategies in various tumour settings
- Deliver an overview on the management of challenging clinical situations faced by practicing oncologists in daily practice
- Understand the role of immunotherapy in diverse cancer settings – focusing on its application in perioperative strategies and its management in special patient populations
- Foster the ability to manage complex oncological cases – emphasizing the use of multidisciplinary and molecular tumour boards to optimize treatment plans and improve patient outcomes in challenging clinical scenarios
Co-Chairs
- Christina Ruhlmann, Denmark
- Radu Vidra, Romania
In addition to the course registration and the hotel accommodation, a travel grant of maximum 400 euros is offered to non-local participants as a contribution versus their travel costs (excluding Visa costs).
Participants must supply proof of travel as appropriate (tickets and receipts/invoices).
The reimbursement will be processed after the course according to the rules below:
Distance |
Reimbursement per return trip |
|---|---|
Up to 100 km |
EUR 70.00 |
101 > 399 km |
EUR 150.00 |
> 400 km |
Please visit this page and use the rail or flight calculator by inserting the city of departure and the city of arrival; then refer to Table 2 (on the same page) to check the reimbursement amount corresponding to the calculated distance. |
*Place of work | |
The programme of this event has been accredited with 10 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
